Looking for the latest health news?
Look at the latest hospital news, the best health news, and the best business publications in the health sector. The health news section shows daily news that is relevant to the industrial sectors are displayed in the healthcare sector's news section.
AstraZeneca has licensed an investigational EGFR degrader from Pinetree Therapeutics for an upfront payment of million bolstering its oncology pipeline amid growing demand for targeted cancer therapies in US hospitals
Redefine Healthcare has reported that David WellsRoth has become the first surgeon to perform roboticassisted spine surgery in an ambulatory surgery centre using the eCential Robotics platform
Medtronic has enrolled the first patient in its ENDURANCE postapproval study evaluating the Altaviva implantable tibial neuromodulation device for the treatment of urge urinary incontinence The first procedure was carried out at Axia Womens Health in...
Gwinnett Hospital is finalizing its story tower project set to significantly boost bed capacity and operational capabilities for regional healthcare delivery
Life Spine Inc has received k clearance from the US Food and Drug Administration for expanded indications of its ARx SAI Sacral Alar Iliac Spinal Fixation System
Olympus Corporation has received k clearance from the US Food and Drug Administration for its POWERSEAL Open Extended Jaw SealerDivider expanding its advanced bipolar surgical energy portfolio
TytoCare a virtual care company focused on delivering primary healthcare at home has received US Food and Drug Administration FDA De Novo clearance for its AIpowered eardrum analysis solution
Pixee Medical a company specialising in augmented reality AR navigation for orthopaedic surgery has received US Food and Drug Administration FDA k clearance for its Knee NexSight solution
Medtronic has received CE marking for its ApexCut surgical blades a new range of powered instruments designed for ear nose and throat ENT procedures
Merck announced that the HartScottRodino antitrust waiting period for its pending acquisition of Terns Pharmaceuticals has expired advancing the major pharma deal forward
